Institutional members access full text with Ovid®

Share this article on:

Infliximab and Adalimumab Use During Breastfeeding

Fritzsche, Juliane PhD*; Pilch, Anna BSc; Mury, Dina MD, PhD; Schaefer, Christof MD, PhD*; Weber-Schoendorfer, Corinna MD, PhD*

Journal of Clinical Gastroenterology: September 2012 - Volume 46 - Issue 8 - p 718–719
doi: 10.1097/MCG.0b013e31825f2807
Letters to the Editor

*Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy, Charité Universitätsmedizin Berlin, Berlin, Germany

Immundiagnostik AGBensheim, Germany

Department of Gynecology, University Medical Center Hamburg-Eppendorf Hamburg, Germany

Funded by the German Federal Ministry of Health (J.F., C.S., and C.W-S.).

The authors declare that they have nothing to disclose.

© 2012 Lippincott Williams & Wilkins, Inc.